Merck and Ridgeback begin Phase III trial of molnupiravir for Covid-19
Merck's Antiviral Could Be Just What Covid Was Waiting For | WIRED UK
Glucophage®, Glucophage XR® - Expertise
Merck Issues Voluntary Nationwide Recall of CUBICIN® (daptomycin for injection) 500 mg, Lot 934778, Due to Presence of Particulate Matter Identified as Glass Particles - Merck.com
FDA authorizes Merck's Covid-19 pill, but stresses its use should be limited
FDA authorizes Merck pill molnupiravir to treat COVID-19 - CNET
Merck's Covid Pill Might Pose Risks for Pregnant Women - The New York Times
Merck Covid-19 treatment pill 'a very powerful tool to add to the toolbox'
Merck's (MRK) Covid Drug Linked to Viable, Spreading Mutants, Study Says - Bloomberg
Merck's COVID-19 treatment pill molnupiravir submitted to FDA for emergency use authorization - CBS News
Japan seeking supply of Merck's oral COVID-19 drug this year | The Asahi Shimbun: Breaking News, Japan News and Analysis
Emory supports Medicines Patent Pool and Merck license agreement for molnupiravir to treat COVID-19
Will Merck's Covid-19 pill be available to lower-income countries? - Pharmaceutical Technology
Merck Covid drug linked to virus mutations, study says
Molnupiravir: Merck's Covid-19 antiviral less effective in new analysis - Pharmaceutical Technology
Merck to share license for COVID-19 pill with other drugmakers to expand access
Merck sues Biden administration over Medicare drug price negotiations
Merck Keeps Striking Out on Expanding Its Cancer-Drug Juggernaut - WSJ
Insight: Merck's COVID pill is last choice for U.S. patients, global use varies | Reuters
Merck | Home
Merck COVID-19 treatment pill authorized by FDA for home use : NPR
Merck agrees to let other drugmakers produce its COVID-19 pill | CBC News
Merck's Covid-19 Pill Heavily Used So Far Despite Concerns - WSJ
Merck's COVID pill loses its lustre: what that means for the pandemic
FDA advisory panel narrowly recommends Merck's Covid pill for emergency use
